2 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Phase 2 | 1 | Recruiting 1 |
Follow Phrontline Biopharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors. TJ102 - Ovarian Cancer | Phase 1 / Phase 2 | Recruiting | Phrontline Biopharma | 150 | 2026-09-29 | 2026-11-12 |
| A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors TJ101 - Lung Cancer (NSCLC), Prostate Cancer | Phase 1 | Recruiting | Phrontline Biopharma | 200 | 2025-08-25 | 2026-01-12 |
Carcinoma, Non-Small-Cell Lung (1) · Esophageal Neoplasms (1) · Lung Neoplasms (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1)
China (2) · United States (2)